Volume 9, 2022

Volume 9, 2022 is now on PubMed »

Systemic lipid peroxidation profile from patients with breast cancer changes according to the lymph nodal metastasis status

β-Galactosylceramidase in cancer: more than a psychosine scavenger

Altos Labs and the quest for immortality: but can we live longer right now?

Towards the prevention of childhood leukemia

HSP90 as an emerging barrier to immune checkpoint blockade therapy

Epigenetics and cancer disparities: when nature might be nurture

Crosstalk between KIF15 and AR in castrate-resistant prostate cancers

A CRISPR-p53 interactome with potential implications for clinical CRISPR/Cas9 use

Potential roles of FAT1 somatic mutation in progression of head and neck cancer

Circulating tumor DNA as a therapy response marker in metastatic colorectal cancer

SLFN11’s surveillance role in protein homeostasis

As expected, based on rapamycin-like p53-mediated gerosuppression, mTOR inhibition acts as a checkpoint in p53-mediated tumor suppression

Leveraging the scientific findings to develop therapeutic strategies for dormant breast cancer cells

lncRNA HOTAIR functions and therapeutic perspectives

MicroRNAs as predictive biomarkers of treatment response to tyrosine kinase inhibitors in hepatocellular carcinoma: how much is missing?

Phenotypic heterogeneity and cooperation in the metastatic cascade

GM-CSF - an oncogenic driver of HER2+ breast leptomeningeal metastasis

A murine model for human early/immature T-cell precursor acute lymphoblastic leukemia (EITP ALL)

Ikaros as a downstream mediator of BCR blockade therapy in B-cell non-Hodgkin lymphoma

Modulation of heme and tumor vascular oxygenation- a novel strategy for lung cancer therapy

Association between tumor mutations and meningioma recurrence in Grade I/II disease

Rapamycin in the context of Pascal’s Wager: generative pre-trained transformer perspective